BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22045831)

  • 1. The effects of N-acetylcysteine and deferoxamine on plasma cytokine and oxidative damage parameters in critically ill patients with prolonged hypotension: a randomized controlled trial.
    Fraga CM; Tomasi CD; Biff D; Topanotti MF; Felisberto F; Vuolo F; Petronilho F; Dal-Pizzol F; Ritter C
    J Clin Pharmacol; 2012 Sep; 52(9):1365-72. PubMed ID: 22045831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetylcysteine plus deferoxamine for patients with prolonged hypotension does not decrease acute kidney injury incidence: a double blind, randomized, placebo-controlled trial.
    Fraga CM; Tomasi CD; Damasio DC; Vuolo F; Ritter C; Dal-Pizzol F
    Crit Care; 2016 Oct; 20(1):331. PubMed ID: 27745551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of N-acetylcysteine and/or deferoxamine on oxidative stress and hyperactivity in an animal model of mania.
    Valvassori SS; Petronilho FC; Réus GZ; Steckert AV; Oliveira VB; Boeck CR; Kapczinski F; Dal-Pizzol F; Quevedo J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):1064-8. PubMed ID: 18403082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of bleomycin-induced lung injury and oxidative stress by N-acetylcysteine plus deferoxamine.
    Teixeira KC; Soares FS; Rocha LG; Silveira PC; Silva LA; Valença SS; Dal Pizzol F; Streck EL; Pinho RA
    Pulm Pharmacol Ther; 2008; 21(2):309-16. PubMed ID: 17904883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetylcysteine for patients with prolonged hypotension as prophylaxis for acute renal failure (NEPHRON).
    Komisarof JA; Gilkey GM; Peters DM; Koudelka CW; Meyer MM; Smith SM
    Crit Care Med; 2007 Feb; 35(2):435-41. PubMed ID: 17205018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-acetylcysteine and deferoxamine reduce pulmonary oxidative stress and inflammation in rats after coal dust exposure.
    Pinho RA; Silveira PC; Silva LA; Luiz Streck E; Dal-Pizzol F; F Moreira JC
    Environ Res; 2005 Nov; 99(3):355-60. PubMed ID: 16307977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of the combination of N-acetylcysteine and desferrioxamine in the prevention and treatment of gentamicin-induced acute renal failure in male Wistar rats.
    Petronilho F; Constantino L; de Souza B; Reinke A; Martins MR; Fraga CM; Ritter C; Dal-Pizzol F
    Nephrol Dial Transplant; 2009 Jul; 24(7):2077-82. PubMed ID: 19204016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergist effects of n-acetylcysteine and deferoxamine treatment on behavioral and oxidative parameters induced by chronic mild stress in rats.
    Arent CO; Réus GZ; Abelaira HM; Ribeiro KF; Steckert AV; Mina F; Dal-Pizzol F; Quevedo J
    Neurochem Int; 2012 Dec; 61(7):1072-80. PubMed ID: 22898295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of N-acetylcysteine on serum creatinine and kidney function: results of a randomized controlled trial.
    Moist L; Sontrop JM; Gallo K; Mainra R; Cutler M; Freeman D; House AA
    Am J Kidney Dis; 2010 Oct; 56(4):643-50. PubMed ID: 20541301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial.
    El-Hamamsy I; Stevens LM; Carrier M; Pellerin M; Bouchard D; Demers P; Cartier R; Page P; Perrault LP
    J Thorac Cardiovasc Surg; 2007 Jan; 133(1):7-12. PubMed ID: 17198774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress in hemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress.
    Swarnalatha G; Ram R; Neela P; Naidu MU; Dakshina Murty KV
    Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):852-8. PubMed ID: 20814119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress and metabolism in animal model of colitis induced by dextran sulfate sodium.
    Damiani CR; Benetton CA; Stoffel C; Bardini KC; Cardoso VH; Di Giunta G; Pinho RA; Dal-Pizzol F; Streck EL
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1846-51. PubMed ID: 17489966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis.
    Ritter C; Andrades ME; Reinke A; Menna-Barreto S; Moreira JC; Dal-Pizzol F
    Crit Care Med; 2004 Feb; 32(2):342-9. PubMed ID: 14758146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of brain creatine kinase activity after renal ischemia is attenuated by N-acetylcysteine and deferoxamine administration.
    Di-Pietro PB; Dias ML; Scaini G; Burigo M; Constantino L; Machado RA; Dal-Pizzol F; Streck EL
    Neurosci Lett; 2008 Mar; 434(1):139-43. PubMed ID: 18304734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of N-acetylcysteine to prevent acute kidney injury after cardiac surgery: a randomized controlled trial.
    Adabag AS; Ishani A; Koneswaran S; Johnson DJ; Kelly RF; Ward HB; McFalls EO; Bloomfield HE; Chandrashekhar Y
    Am Heart J; 2008 Jun; 155(6):1143-9. PubMed ID: 18513531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of N-acetylcysteine plus deferoxamine on oxidative stress and inflammation in dystrophic muscle cells.
    Moraes LH; Bollineli RC; Mizobuti DS; Silveira Ldos R; Marques MJ; Minatel E
    Redox Rep; 2015 May; 20(3):109-15. PubMed ID: 25361473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of N-acetylcysteine plus deferoxamine in lipopolysaccharide-induced acute lung injury in the rat.
    Ritter C; da Cunha AA; Echer IC; Andrades M; Reinke A; Lucchiari N; Rocha J; Streck EL; Menna-Barreto S; Moreira JC; Dal-Pizzol F
    Crit Care Med; 2006 Feb; 34(2):471-7. PubMed ID: 16424730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of protection of N-acetylcysteine (NAC) in acute renal failure related to elective aortic aneurysm repair-a randomized controlled trial.
    Macedo E; Abdulkader R; Castro I; Sobrinho AC; Yu L; Vieira JM
    Nephrol Dial Transplant; 2006 Jul; 21(7):1863-9. PubMed ID: 16522657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) Trial.
    Thiele H; Hildebrand L; Schirdewahn C; Eitel I; Adams V; Fuernau G; Erbs S; Linke A; Diederich KW; Nowak M; Desch S; Gutberlet M; Schuler G
    J Am Coll Cardiol; 2010 May; 55(20):2201-9. PubMed ID: 20466200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetylcysteine attenuates kidney injury in rats subjected to renal ischaemia-reperfusion.
    Nitescu N; Ricksten SE; Marcussen N; Haraldsson B; Nilsson U; Basu S; Guron G
    Nephrol Dial Transplant; 2006 May; 21(5):1240-7. PubMed ID: 16390850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.